Phaeochromocytoma, new genes and screening strategies
Authors:
- Anne‐Paule Gimenez‐RoqueploAGAnne‐Paule Gimenez‐Roqueplo
- Hendrik LehnertHLHendrik Lehnert
- Massimo MannelliMMMassimo Mannelli
- Hartmut NeumannHNHartmut Neumann
- Giuseppe OpocherGOGiuseppe Opocher
- Eamonn R. MaherEMEamonn R. Maher
- Pierre‐François PlouinPPPierre‐François Plouin
- on behalf of the European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working GroupOGon behalf of the European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group
- 7 November 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (6) , 699-705
Abstract
Summary: Following recent advances in the genetics of phaeochromocytomas and paragangliomas, the members of the European Network for the Study of Adrenal Tumours (ENS@T) Phaeochromocytoma Working Group have decided to share their genotyping data and to propose European recommendations for phaeochromocytoma/functional paraganglioma (PH/FPGL) genetic testing. Germline DNA from 642 patients was analysed by ENS@T teams. In 166 patients (25·9%) the disease was familial and caused by germline mutations in VHL (56), SDHB (34), SDHD (31), RET (31) or NF1 (14), causing von Hippel‐Lindau disease, SDHB‐ or SDHD‐PH/FPGL syndromes, multiple endocrine neoplasia type 2 (MEN 2) and type 1 neurofibromatosis (NF1), respectively. In almost 60% of inherited cases it was possible to formulate a probable genetic diagnosis based on family history and/or typical syndromic presentation. Genetic testing revealed mutations in 12·7% of cases with an apparently sporadic presentation. Several clinical characteristics, such as young age at onset, the presence of bilateral, extra‐adrenal or multiple tumours or a malignant tumour, should be seen as indications for genetic testing. The ENS@T Phaeochromocytoma Working Group recommends the genetic testing of all patients with PH and FPGL and suggests a practice algorithm for the management of their exploration.Keywords
This publication has 39 references indexed in Scilit:
- Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma SyndromesThe Journal of Clinical Endocrinology & Metabolism, 2006
- The genetic basis of pheochromocytoma: who to screen and how?Nature Clinical Practice Endocrinology & Metabolism, 2006
- Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditionsHuman Molecular Genetics, 2005
- New Insights in the Genetics of Adrenocortical Tumors, Pheochromocytomas and ParagangliomasHormone and Metabolic Research, 2005
- Malignant pheochromocytoma: current status and initiatives for future progressEndocrine-Related Cancer, 2004
- Provision of genetic services in Europe: current practices and issuesEuropean Journal of Human Genetics, 2003
- VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMASJournal of Urology, 1999
- The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 21997
- RETProto-Oncogene Mutations in Multiple Endocrine Neoplasia Type 2 and Medullary Thyroid CarcinomaHormone Research, 1997
- Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytomaEndocrine Reviews, 1994